Treatment of Xanthelasma Palpebrarum with Hypothyroidism or Other Underlying Medical Disorder

Xanthelasma palpebrarum may develop in the setting of an underlying systemic medical disorder. When such a condition is present, the protocol is shaped by that systemic context — managing the underlying disorder becomes a central component of care.

Clinical Scenario

Xanthelasma palpebrarum with an underlying medical disorder — for example, hypothyroidism. The presence of a systemic condition distinguishes this presentation and informs the management approach.

Treatment Goal

Regression of xanthelasma plaques through correction of the underlying medical disorder. In some cases, treating the systemic cause can lead to improvement of the xanthelasma itself.

Treatment Overview (partial)

Management involves referral to a primary care physician to evaluate and treat the identified underlying medical disorder. Addressing the systemic cause may, in some cases, lead to…

Instant Access to Structured Evidence-Based Regimens

References

DOI: 10.1097/01.PRS.0000025626.70065.2B

In some cases, treatment of the underlying medical disorder can cause regression, as in the case of thyroid hormone replacement therapy for hypothyroidism.

View source ↗